Loading...

Basilea Pharmaceutica AG

BPMUF•PNK
Healthcare
Biotechnology
$69.00
$0.00(0.00%)
U.S. Market opens in 16h 31m

Basilea Pharmaceutica AG (BPMUF) Stock Overview

Explore Basilea Pharmaceutica AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap846.9M
P/E Ratio16.36
EPS (TTM)$7.12
ROE0.35%
Fundamental Analysis

AI Price Forecasts

1 Month$73.25
3 Months$62.06
1 Year Target$70.77

BPMUF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Basilea Pharmaceutica AG (BPMUF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $70.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.36 and a market capitalization of 846.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-2.82%
3-Month Change
-2.82%
6-Month Change
15.06%
Year-to-Date (YTD) Change
9.09%
1-Year Change
45.26%
3-Year Change
32.69%
5-Year Change
32.97%
All-Time (Max) Change
-48.50%

Contact Information

https://www.basilea.com
41 61 606 11 11
Grenzacherstrasse 487, Allschwil, NaN, 4058

Company Facts

164 Employees
IPO DateJun 9, 2015
CountryCH
Actively Trading

Frequently Asked Questions